Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Overlap between Central and Peripheral Transcriptomes in Parkinson's Disease but Not Alzheimer's Disease. | Int J Mol Sci | 2022 | 35563596 | PubTator, text mining | PubMed |
| Revealing the Immune Heterogeneity between Systemic Lupus Erythematosus and Rheumatoid Arthritis Based on Multi-Omics Data Analysis. | Int J Mol Sci | 2022 | 35563556 | PubTator, text mining | PubMed |
| Exploration of the pathogenesis of Sjögren's syndrome via DNA methylation and transcriptome analyses. | Clin Rheumatol | 2022 | 35562622 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer. | Cell Prolif | 2022 | 35560676 | PubTator, text mining | PubMed |
| Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors. | Front Immunol | 2022 | 35558065 | PubTator, text mining | PubMed |
| ICARUS, an interactive web server for single cell RNA-seq analysis. | Nucleic Acids Res | 2022 | 35536286 | PubTator, text mining | PubMed |
| Pan-Cancer HLA Gene-Mediated Tumor Immunogenicity and Immune Evasion. | Mol Cancer Res | 2022 | 35533264 | PubTator, text mining | PubMed |
| Identification of immune-related biomarkers associated with tumorigenesis and prognosis in skin cutaneous melanoma. | Am J Cancer Res | 2022 | 35530289 | PubTator, text mining | PubMed |
| Impact of Platelets to Lymphocytes Ratio and Lymphocytes during Radical Concurrent Radiotherapy and Chemotherapy on Patients with Nonmetastatic Esophageal Squamous Cell Carcinoma. | J Oncol | 2022 | 35528243 | PubTator, text mining | PubMed |
| Bioinformatics analysis reveals molecular connections between non-alcoholic fatty liver disease (NAFLD) and COVID-19. | J Cell Commun Signal | 2022 | 35525888 | PubTator, text mining | PubMed |
| Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma. | Genes Immun | 2022 | 35525858 | PubTator, text mining | PubMed |
| Single-cell characterization of malignant phenotypes and microenvironment alteration in retinoblastoma. | Cell Death Dis | 2022 | 35523772 | PubTator, text mining | PubMed |
| EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients. | Front Cell Dev Biol | 2022 | 35517503 | PubTator, text mining | PubMed |
| Comprehensive analysis to identify noncoding RNAs mediated upregulation of maternal embryonic leucine zipper kinase (MELK) correlated with poor prognosis in hepatocellular carcinoma. | Aging (Albany NY) | 2022 | 35511171 | PubTator, text mining | PubMed |
| miRNAs-mediated overexpression of Periostin is correlated with poor prognosis and immune infiltration in lung squamous cell carcinoma. | Aging (Albany NY) | 2022 | 35508298 | PubTator, text mining | PubMed |
| Association of HLA-DPA1 polymorphism with prolonged mechanical ventilation in patients undergoing liver transplantation. | Korean J Anesthesiol | 2022 | 35505457 | PubTator, text mining | PubMed |
| Characterizing the diversity of MHC conserved extended haplotypes using families from the United Arab Emirates. | Sci Rep | 2022 | 35504942 | PubTator, text mining | PubMed |
| Single-cell analysis of human testis aging and correlation with elevated body mass index. | Dev Cell | 2022 | 35504286 | PubTator, text mining | PubMed |
| Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules. | PeerJ | 2022 | 35502206 | PubTator, text mining | PubMed |
| The First Case of Familiar Anti-leucine-rich Glioma-Inactivated1 Autoimmune Encephalitis: A Case Report and Literature Review. | Front Neurol | 2022 | 35493840 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=44